10:27 AM EDT, 05/07/2024 (MT Newswires) -- Ashland (ASH) has agreed to sell its nutraceuticals business to Turnspire Capital Partners, the companies said Tuesday.
The deal is expected to close in Q3.
Price: 98.32, Change: +0.98, Percent Change: +1.01